Ideal prognostic model in lung squamous cell carcinoma.
作者信息
Kinoshita Tomonari
机构信息
Department of Thoracic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
出版信息
Transl Lung Cancer Res. 2020 Jun;9(3):430-431. doi: 10.21037/tlcr.2020.03.22.
Abstract
摘要
相似文献
1
Ideal prognostic model in lung squamous cell carcinoma.
Transl Lung Cancer Res. 2020 Jun;9(3):430-431. doi: 10.21037/tlcr.2020.03.22.
2
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
Clin Transl Oncol. 2021 Nov;23(11):2368-2381. doi: 10.1007/s12094-021-02638-1. Epub 2021 May 24.
3
[Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma].
Zhonghua Zhong Liu Za Zhi. 2021 May 23;43(5):569-573. doi: 10.3760/cma.j.cn112152-20191126-00763.
4
Survival-associated N-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification.
BMC Cancer. 2021 Nov 24;21(1):1265. doi: 10.1186/s12885-021-08939-6.
5
The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis.
Biosci Rep. 2017 Aug 31;37(4). doi: 10.1042/BSR20170852. Epub 2017 Jul 19.
6
Survival comparison of Three histological subtypes of lung squamous cell carcinoma: A population-based propensity score matching analysis.
Lung Cancer. 2020 Apr;142:13-19. doi: 10.1016/j.lungcan.2020.01.020. Epub 2020 Feb 3.
7
Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.
Cancer Res. 1994 Sep 1;54(17):4671-5.
8
A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.
Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1207-1214. doi: 10.1080/21691401.2017.1366334. Epub 2017 Aug 24.
9
Construction of a prognostic model for lung squamous cell carcinoma based on seven N6-methylandenosine-related autophagy genes.
Math Biosci Eng. 2021 Aug 9;18(5):6709-6723. doi: 10.3934/mbe.2021333.
10
miR-448 is a novel prognostic factor of lung squamous cell carcinoma and regulates cells growth and metastasis by targeting DCLK1.
Biomed Pharmacother. 2017 May;89:1227-1234. doi: 10.1016/j.biopha.2017.02.017. Epub 2017 Mar 17.
引用本文的文献
1
Identification of and expression as novel candidate biomarkers for predicting the benefit of immunotherapy in lung squamous cell carcinoma.
Ann Transl Med. 2021 Jul;9(13):1081. doi: 10.21037/atm-21-2186.
本文引用的文献
1
Prognostic model based on circular RNA circPDK1 for resected lung squamous cell carcinoma.
Transl Lung Cancer Res. 2019 Dec;8(6):907-919. doi: 10.21037/tlcr.2019.11.20.
2
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.
J Natl Compr Canc Netw. 2019 Dec;17(12):1464-1472. doi: 10.6004/jnccn.2019.0059.
3
Predictive value of a prognostic model based on pathologic features in lung invasive adenocarcinoma.
Lung Cancer. 2019 May;131:14-22. doi: 10.1016/j.lungcan.2019.03.002. Epub 2019 Mar 4.
4
Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis.
Transl Oncol. 2018 Aug;11(4):999-1006. doi: 10.1016/j.tranon.2018.05.008. Epub 2018 Jun 27.
5
Emerging landscape of circular RNAs in lung cancer.
Cancer Lett. 2018 Jul 28;427:18-27. doi: 10.1016/j.canlet.2018.04.006. Epub 2018 Apr 11.
6
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors.
J Thorac Oncol. 2015 Sep;10(9):1341-1348. doi: 10.1097/JTO.0000000000000628.
7
Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung.
J Thorac Oncol. 2015 Apr;10(4):619-28. doi: 10.1097/JTO.0000000000000480.
8
A clinicopathological study of resected small-sized squamous cell carcinomas of the peripheral lung: prognostic significance of serum carcinoembryonic antigen levels.
Ann Thorac Cardiovasc Surg. 2013;19(5):351-7. doi: 10.5761/atcs.oa.12.01843. Epub 2012 Dec 13.
9
Cumulative incidence of and predictive factors for lung cancer in IPF.
Respirology. 2009 Jul;14(5):723-8. doi: 10.1111/j.1440-1843.2009.01547.x.
10
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.
Mayo Clin Proc. 2008 May;83(5):584-94. doi: 10.4065/83.5.584.
Zotero 插件